Skin and Connective Tissue Diseases

445 trials 165 recruiting

Filter these 445 trials by phase, country and sponsor.

Open in Search →

A Phase 4 (Phase 2 in European Union), Open-Label, Multicenter Study Evaluating the Absorption and Systemic Pharmacokinetics and HPA Axis Su… Recruiting

2024-520058-39-00 Plaque Psoriasis 4 2020-12-28
Study evaluating near-infrared imaging coupled with indocyanine green for intraoperative monitoring of resection margins in ENT surgery Recruiting

2022-502737-26-00 epidermoid carcinoma 4 2020-12-15
PAmidronate for Pain in Sternocostoclavicular hyperostosis: the PAPS-study, a double-blind randomized placebo-controlled trial Recruiting

2023-510309-16-00 Inflammation of sternal region 5 2020-12-08
Electrochemotherapy versus standard radiotherapy for the treatment of basal cell carcinoma Recruiting

2024-519066-49-01 Basal cell carcinoma (non-melanoma skin cancer) 6 2020-11-16
Subcutaneous Injections of Sodium Thiosulfate for ectopic calcifications or ossifications. A pilot study. Recruiting

2024-511620-13-00 Patient presenting with: - ectopic ossification seconda 4 2020-06-05
Extension study to assess effects of non-interrupted versus interrupted and long term treatment of two dose regimens on efficacy and safety … Recruiting

2023-508956-20-00 Hidradenitis suppurativa 5 2020-03-12
Randomized Controlled Trial comparing two groups of Patients with High-Risk, Localized Soft Tissue Sarcoma of the Extremity: the first one r… Recruiting

2024-517858-10-00 high-risk soft tissue sarcoma of the extremity (undiffe 4 2019-12-11
Investigating How Anti-Infection Drugs Are Processed in the Bodies of Healthy People and Severely Burned Patients in the Intensive Care Unit Recruiting

2024-517260-39-00 Combustion 3 2017-09-15
A trial to explore the efficacy and safety of IDOR-1117-2520 in adults with moderate to severe chronic plaque psoriasis, with or without pso… Ended

2025-523051-64-00 Moderate to severe chronic plaque psoriasis 4 2026-01-26
Safety and Efficacy of AT-004 in Patients with Acne Vulgaris Ended

2025-521510-25-00 Acne vulgaris 4 2026-01-13
A Study Evaluating BFB759 in Atopic Dermatitis Ended

2025-521624-30-00 Atopic dermatitis 4 2026-01-08
A study to investigate the efficacy and safety of TRIV-509 compared with placebo in adults with moderate to severe atopic dermatitis Ended

2025-522113-35-00 Atopic dermatitis 4 2026-01-07
Study of BLU-808 in Chronic Inducible Urticaria and Chronic Spontaneous Urticaria Ended

2024-520031-33-00 Chronic Inducible Urticaria and Chronic Spontaneous Urt 4 2025-09-16
A clinical study of tulisokibart in people with hidradenitis suppurativa (MK-7240-012) Ended

2024-520039-33-00 Hidradenitis Suppurativa 10 2025-08-11
Early recognition of progressive lung fibrosis in systemic rheumatic diseases: a characterization of the pulmonary environment through extra… Ended

2024-516304-42-00 Patients with connective tissue diseases at high risk o 4 2025-05-30
Phase 3 study to evaluate the efficacy and safety of subcutaneous tildrakizumab in subjects with moderate to severe genital psoriasis. Ended

2024-515672-12-00 Moderate to Severe Genital Psoriasis 5 2025-05-27
A Randomized, Active-Controlled, Double-Blind, Phase 3 Study to Compare Efficacy and Safety of CT-P55 with Cosentyx in Patients with Moderat… Ended

2024-513348-27-00 Plaque psoriasis 5 2025-05-09
A Phase 3 Study of Barzolvolimab in Patients with Chronic Spontaneous Urticaria (EMBARQ – CSU1) Ended

2024-513210-36-00 Chronic Spontaneous Urticaria 5 2025-04-04
A study to investigate the efficacy and safety of subcutaneous sonelokimab versus placebo in participants aged 18 years and over with active… Ended

2024-516213-20-00 Psoriatic arthritis 5 2025-03-25
A Phase 2, Open-Label, Extension Study to Evaluate Long Term Safety and Clinical Activity of Briquilimab in Participants from Jasper-Sponsor… Ended

2024-517830-17-00 Chronic Urticaria 4 2025-03-14
CLINICAL STUDY TO TEST STEM CELLS FOR THE TREATMENT OF LONG-TERM, NON-HEALING VENOUS LEG ULCERS Ended

2024-512720-11-00 chronic venous ulcers (CVU) 5 2025-01-16
A study to learn how well bimekizumab works and how safe it is in adults with psoriatic arthritis Ended

2024-511738-11-00 Psoriatic arthritis 5 2024-12-18
Selective Treatment of Oral Povorcitinib in Prurigo Nodularis Study 2 (STOP-PN2) Ended

2024-511881-35-00 Prurigo Nodularis 5 2024-12-17
A Phase 3 Study of Barzolvolimab in Patients with Chronic Spontaneous Urticaria (EMBARQ – CSU1) Ended

2024-513208-32-00 Chronic Spontaneous Urticaria 5 2024-12-16